Annual D&A
$24.46M$4.30M+21.34%
Summary
- Current Value
- As of today, AGL annual D&A is $24.46M, up +21.34% on
- Historical Performance
- AGL annual D&A is up +66.76% over the past 3 years, and down -40.93% over the past 5 years
- All-Time High Comparison
- AGL annual D&A is currently -40.93% below its historical high of $41.41M set on
- 3-Year Low Comparison
- AGL annual D&A is +77.63% above its 3-year low of $13.77M reached on an earlier date
- Sector Comparison
- AGL annual D&A is higher than 79.80% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $24.46M | +21.3% | +66.8% | -40.9% | -40.9% | |
| Quarterly D&A | $7.43M | +19.5% | +115.4% | +112.2% | +120.9% | |
| TTM D&A | $28.12M | +21.6% | +108.2% | +171.8% | +736.1% | |
| Price | $0.99 | -73.1% | -95.2% | – | – | |
| Annual SG&A | $268.91M | -5.9% | -37.1% | +118.9% | +118.9% | |
| Annual Total Expenses | $6.35B | +39.6% | +235.3% | +604.7% | +604.7% | |
| Annual Operating Expenses | $293.38M | -2.8% | -33.0% | +117.2% | +117.2% | |
| Annual Revenue | $6.06B | +40.4% | +230.5% | +662.9% | +662.9% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $24.46M | at high | |
| 5Y | $24.46M | at high | |
| All | $41.41M | -40.9% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $13.77M | N/A | +77.6% |
| 5Y | $13.77M | +77.6% | |
| All | $13.77M | +77.6% |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $24.46M | +21.3% | |
| $20.16M | +46.4% | |
| $13.77M | -6.1% |
| Year | Value | Change |
|---|---|---|
| $14.67M | +4.0% | |
| $14.10M | -66.0% | |
| $41.41M | - |
FAQ
What is the current annual D&A of AGL?
As of today, AGL annual D&A is $24.46M
What is 1-year change in AGL annual D&A?
AGL annual D&A is up +21.34% year-over-year
What is 3-year change in AGL annual D&A?
AGL annual D&A is up +66.76% over the past 3 years
How far is AGL annual D&A from its all-time high?
AGL annual D&A is currently -40.93% below its historical high of $41.41M set on December 31, 2019
How does AGL annual D&A rank versus sector peers?
AGL annual D&A is higher than 79.80% of companies in Healthcare sector
When is AGL next annual earnings release?
The next annual earnings release for AGL is on
Quarterly D&A
$7.43M$111.00K+1.52%
Summary
- Current Value
- As of today, AGL quarterly D&A is $7.43M, up +1.52% on
- Historical Performance
- AGL quarterly D&A is up +19.49% year-over-year, and up +115.36% over the past 3 years
- All-Time High Comparison
- AGL quarterly D&A is currently at its all-time high
- 3-Year Low Comparison
- AGL quarterly D&A is +90.17% above its 3-year low of $3.91M reached on an earlier date
- Sector Comparison
- AGL quarterly D&A is higher than 80.51% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $7.43M | +1.5% | +19.5% | +115.4% | +112.2% | |
| Annual D&A | $24.46M | – | +21.3% | +66.8% | -40.9% | |
| TTM D&A | $28.12M | +4.5% | +21.6% | +108.2% | +171.8% | |
| Price | $0.99 | +0.5% | -73.1% | -95.2% | – | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Total Expenses | $1.55B | +3.1% | -1.4% | +113.1% | +375.6% | |
| Quarterly Operating Expenses | $52.11M | -7.2% | -15.5% | +1.2% | +63.2% | |
| Quarterly Revenue | $1.44B | +2.9% | -1.1% | +106.6% | +359.0% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $7.43M | at high | |
| 3Y | $7.43M | at high | |
| 5Y | $7.43M | at high | |
| All | $7.43M | at high |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.49M | N/A | +14.4% |
| 3Y | $3.91M | N/A | +90.2% |
| 5Y | $3.04M | +144.3% | |
| All | $3.04M | +144.3% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of AGL?
As of today, AGL quarterly D&A is $7.43M
What is AGL quarterly D&A most recent change?
AGL quarterly D&A was up +1.52% on September 30, 2025
What is 1-year change in AGL quarterly D&A?
AGL quarterly D&A is up +19.49% year-over-year
How far is AGL quarterly D&A from its all-time high?
AGL quarterly D&A is currently at its all-time high
How does AGL quarterly D&A rank versus sector peers?
AGL quarterly D&A is higher than 80.51% of companies in Healthcare sector
When is AGL next earnings release?
The next earnings release for AGL is on
TTM D&A
$28.12M$1.21M+4.50%
Summary
- Current Value
- As of today, AGL TTM D&A is $28.12M, up +4.50% on
- Historical Performance
- AGL TTM D&A is up +21.64% year-over-year, and up +108.24% over the past 3 years
- All-Time High Comparison
- AGL TTM D&A is currently at its all-time high
- 3-Year Low Comparison
- AGL TTM D&A is +104.18% above its 3-year low of $13.77M reached on an earlier date
- Sector Comparison
- AGL TTM D&A is higher than 79.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $28.12M | +4.5% | +21.6% | +108.2% | +171.8% | |
| Annual D&A | $24.46M | – | +21.3% | +66.8% | -40.9% | |
| Quarterly D&A | $7.43M | +1.5% | +19.5% | +115.4% | +112.2% | |
| Price | $0.99 | +0.5% | -73.1% | -95.2% | – | |
| TTM SG&A | -$6.63B | -2805.1% | -2521.2% | -3455.9% | -7289.8% | |
| TTM Revenue | $5.89B | -0.3% | +5.2% | +137.2% | +555.9% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $28.12M | at high | |
| 3Y | $28.12M | at high | |
| 5Y | $28.12M | at high | |
| All | $28.12M | at high |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $24.46M | N/A | +14.9% |
| 3Y | $13.77M | N/A | +104.2% |
| 5Y | $13.50M | +108.2% | |
| All | $3.36M | +736.1% |
TTM D&A History
FAQ
What is the current TTM D&A of AGL?
As of today, AGL TTM D&A is $28.12M
What is AGL TTM D&A most recent change?
AGL TTM D&A was up +4.50% on September 30, 2025
What is 1-year change in AGL TTM D&A?
AGL TTM D&A is up +21.64% year-over-year
How far is AGL TTM D&A from its all-time high?
AGL TTM D&A is currently at its all-time high
How does AGL TTM D&A rank versus sector peers?
AGL TTM D&A is higher than 79.73% of companies in Healthcare sector
When is AGL next earnings release?
The next earnings release for AGL is on
Data Sources & References
- AGL Official Website www.agilonhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1831097/000162828025048839/0001628280-25-048839-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1831097/000162828025007721/0001628280-25-007721-index.htm
- AGL Profile on Yahoo Finance finance.yahoo.com/quote/AGL
- AGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/agl